AYTU

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aytu BioScience Inc

NASDAQ | AYTU

2.31

USD

$0.00

(

0.00%

)

At Close (As of Sep 17, 2025)

$21.01M

Market Cap

-

P/E Ratio

-1.49

EPS

$2.85

52 Week High

$0.95

52 Week Low

HEALTHCARE

Sector

AYTU Chart

Recent Chart
Price Action

AYTU Technicals

Tags:

AYTU Earnings

Yearly Income Statement (As of Jun 30, 2024)

Field Value (USD)
Gross Profit $49M
Total Revenue $81M
Cost Of Revenue $32M
Costof Goods And Services Sold $32M
Operating Income -$5.3M
Selling General And Administrative $23M
Research And Development $2.8M
Operating Expenses $61M
Investment Income Net -
Net Interest Income -$4.8M
Interest Income -
Interest Expense $4.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.3M
Income Before Tax -$14M
Income Tax Expense $1.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$16M
Comprehensive Income Net Of Tax -
Ebit -$9.3M
Ebitda -$1M
Net Income -$16M

Revenue & Profitability

Earnings Performance

AYTU Financials

yearly Balance Sheet (As of Jun 30, 2024)

Field Value (USD)
Total Assets $118M
Total Current Assets $62M
Cash And Cash Equivalents At Carrying Value $20M
Cash And Short Term Investments $20M
Inventory $13M
Current Net Receivables $24M
Total Non Current Assets $56M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $52M
Intangible Assets Excluding Goodwill $52M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $5.6M
Other Non Current Assets -
Total Liabilities $90M
Total Current Liabilities $62M
Current Accounts Payable $10M
Deferred Revenue -
Current Debt -
Short Term Debt $5M
Total Non Current Liabilities $28M
Capital Lease Obligations -
Long Term Debt $11M
Current Long Term Debt $4.3M
Long Term Debt Noncurrent -
Short Long Term Debt Total $16M
Other Current Liabilities $47M
Other Non Current Liabilities $4.5M
Total Shareholder Equity $28M
Treasury Stock -
Retained Earnings -$320M
Common Stock $1K
Common Stock Shares Outstanding $5.5M

yearly Cash Flow (As of Jun 30, 2024)

Field Value (USD)
Operating Cashflow -$1.4M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $8.3M
Capital Expenditures $0
Change In Receivables -
Change In Inventory $2.3M
Profit Loss -
Cashflow From Investment -$329K
Cashflow From Financing -$1.3M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$16M

yearly Income Statement (As of Jun 30, 2024)

Field Value (USD)
Gross Profit $49M
Total Revenue $81M
Cost Of Revenue $32M
Costof Goods And Services Sold $32M
Operating Income -$5.3M
Selling General And Administrative $23M
Research And Development $2.8M
Operating Expenses $61M
Investment Income Net -
Net Interest Income -$4.8M
Interest Income -
Interest Expense $4.8M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $8.3M
Income Before Tax -$14M
Income Tax Expense $1.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$16M
Comprehensive Income Net Of Tax -
Ebit -$9.3M
Ebitda -$1M
Net Income -$16M

AYTU News

AYTU Profile

Aytu BioScience Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Aytu BioScience Inc. is a specialty pharmaceutical company based in Englewood, Colorado, committed to advancing healthcare through the development and commercialization of innovative therapeutics. The company's portfolio targets critical health issues, including hypogonadism, respiratory conditions, insomnia, and male infertility, addressing significant unmet medical needs both domestically and internationally. Aytu's strategic focus on niche markets positions it to provide unique solutions in the pharmaceutical landscape, ultimately aiming to enhance patient quality of life while achieving sustainable growth.

ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
PLTR
-1.13%
$168.33
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
KDLY
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.95%
$92.98
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
OPI
-31.80%
$0.56
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
ATYR
-5.09%
$1.02
JD
+1.52%
$35.24
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
FAAS
-6.04%
$0.09
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
BABA
+2.39%
$166.09
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
HIMS
-1.06%
$50.35
CAN
+0.23%
$0.80
ETWO
0.00%
$3.30
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
SPRC
+142.93%
$4.47
NIO
+6.05%
$7.44
QBTS
+19.44%
$22.66
GRAB
-3.48%
$6.10
TSLA
+1.00%
$425.86
AAL
+0.84%
$12.51
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
SOFI
-1.02%
$27.14
RGTI
+9.92%
$21.98
TPIC
-45.91%
$0.12
PLTR
-1.13%
$168.33
DNN
+1.40%
$2.53
AXDX
-61.36%
$0.03
ADAP
-1.22%
$0.08
BBD
+2.95%
$3.30
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
INTC
-1.46%
$24.90
BMNR
+1.98%
$57.04
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
NAKA
-4.66%
$1.43
KDLY
-4.66%
$1.43
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.95%
$92.98
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
IONQ
+4.97%
$65.36
ABEV
0.00%
$2.36
AIRE
-1.57%
$1.25
LDI
+2.70%
$4.55
RIOT
+0.82%
$17.66
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
OPI
-31.80%
$0.56
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
BINI
-10.60%
$0.05
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
NWTN
+12.58%
$1.70
CWD
+19.05%
$7.56
ATYR
-5.09%
$1.02
JD
+1.52%
$35.24
ITUB
+1.82%
$7.27
INFY
+3.60%
$17.67
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
FAAS
-6.04%
$0.09
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
KEY
+0.42%
$18.71
BABA
+2.39%
$166.09
BAC
+1.41%
$51.37
BTE
-2.49%
$2.54
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
T
-0.97%
$29.33
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
HIMS
-1.06%
$50.35
CAN
+0.23%
$0.80
ETWO
0.00%
$3.30
PEB
+2.03%
$11.79
RAYA
-3.83%
$0.04
GDXD
+2.45%
$1.25
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.